William D. Turner
Chief Regulatory Officer at Vera Therapeutics, Inc. (VERA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 25SEC | VERAVera Therapeutics, Inc. | Sell | 2,18745,313 held (−5%) | $41.98 | $92K | -33.6% |
| Dec 17SEC | VERAVera Therapeutics, Inc. | Sell Plan | 10,00022,500 held (−31%) | $50.08 | $501K | -44.3% |
| Dec 10SEC | VERAVera Therapeutics, Inc. | Sell Plan | 10,00022,500 held (−31%) | $45.31 | $453K | -38.5% |
| Dec 4SEC | VERAVera Therapeutics, Inc. | Sell Plan | 10,00022,500 held (−31%) | $40.00 | $400K | -30.3% |
- Sell
Chief Regulatory Officer William D. Turner sold $501K of VERA at $50.08 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer William D. Turner sold $453K of VERA at $45.31 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer William D. Turner sold $400K of VERA at $40.00 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.